Abstract
The population of the Middle East is a growing population characterized by increasing prevalence of metabolic syndrome, diabetes, and obesity. Both myocardial perfusion imaging (MPI) and coronary artery calcification (CAC) have a well-validated role in the diagnosis and prognosis of coronary artery disease (CAD). In the recent years, adding CAC score to myocardial perfusion imaging has been associated with incremental diagnostic and prognostic value. The aim of this paper is to review the diagnostic and prognostic value of adding CAC score to nuclear MPI in the Middle Eastern patients in the face of increasing prevalence of metabolic syndrome and CAD risk factors. Since limited local data are available from the Middle East, this review will focus on reports on similar cohorts from the western world.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
